Cases 21 - 30 of 106
Eagle Pharmaceuticals, Inc. v. Accord Healthcare Inc. et al
as 1:2022cv00704
Plaintiff:
Eagle Pharmaceuticals, Inc.
Defendant:
Accord Healthcare Inc., Accord Healthcare Ltd. and Intas Pharmaceuticals Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NOVARTIS PHARMACEUTICALS CORPORATION et al v. ACCORD HEALTHCARE INC. et al
as 1:2022cv00431
Plaintiff:
NOVARTIS PHARMACEUTICALS CORPORATION and Dana-Farber Cancer Institute, Inc.
Defendant:
ACCORD HEALTHCARE INC. and INTAS PHARMACEUTICALS LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Accord Healthcare Inc. et al
as 1:2022cv00744
Plaintiff:
Novartis Pharmaceuticals Corporation and Dana-Farber Cancer Institute, Inc.
Defendant:
Accord Healthcare Inc. and Intas Pharmaceuticals Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BRISTOL-MYERS SQUIBB COMPANY v. ACCORD HEALTHCARE INC.
as 1:2022cv03743
Plaintiff:
BRISTOL-MYERS SQUIBB COMPANY
Defendant:
ACCORD HEALTHCARE INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. ACCORD HEALTHCARE, INC.
as 2:2022cv00856
Plaintiff:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant:
ACCORD HEALTHCARE, INC., ACCORD HEALTHCARE, LTD. and INTAS PHARMACEUTICALS, LTD.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Celgene Corporation et al v. Accord Healthcare Inc.
as 1:2021cv01795
Plaintiff:
Celgene Corporation and Celgene International Sarl
Defendant:
Accord Healthcare Inc.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Accord Healthcare Inc.
as 1:2021cv00952
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Defendant:
Accord Healthcare Ltd., Intas Pharmaceuticals Ltd. and Accord Healthcare Inc.
Cause Of Action: 35 U.S.C. § 271
Taiho Pharmaceutical Co., Ltd. et al v. Accord Healthcare Inc. et al
as 1:2021cv00838
Plaintiff:
Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd.
Defendant:
Intas Pharmaceuticals Ltd. and Accord Healthcare Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
